NEWARK, DELAWARE – A group of national and Delaware based partners will host the Delaware Bioscience Business Roundtable (BBR) event featuring Governor Jack Markell and bioscience leaders to discuss the state’s bioscience industry. Bioscience represents a significant source of economic development in Delaware. In 2008, nearly 12,000 people were employed by the industry. Industry activities generate an additional 16,000 jobs annually in addition to the 12,000 employed directly by the industry.
BBR is a unified voice of leaders representing the biotechnology, life sciences, and biomedical research industries — collectively known as the bioscience community. Its mission is to promote public policies that on a local, state, and federal level safeguard and sustain America’s place as the world leader in bioscience. The three tenets of BBR are to promote access, prevention, and encourage innovation by building bridges of understanding between government leaders, the business community, and academia on key issues facing Delaware and the United States’ dynamic bioscience community.
The event will be hosted locally by the Delaware Bioscience Association, Delaware State Chamber of Commerce, Delaware AFL-CIO, Central Delaware Chamber of Commerce, We Work for Health, Greater Newark Network, Delaware Chapter of the American Diabetes Association, Delaware HIV Consortium, New Castle County Chamber of Commerce, and nationally by the Biotechnology Industry Organization (BIO), the National Venture Capital Association (NVCA), the Pharmaceutical Research and Manufacturers of America (PhRMA), and the U.S. Chamber of Commerce.